Ece1 and Tbx1 define distinct pathways to aortic arch morphogenesis

Developmental Dynamics

Volumn 228, Issue 1, 2003, Pages 95-104

  Morishima, Masae ^a   Yanagisawa, Hiromi ^b   Yanagisawa, Masashi ^c   Baldini, Antonio ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Aortic arch abnormalities; DiGeorge syndrome; Endothelin 1 pathway; Tbx1

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; GENE PRODUCT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DIGEORGE SYNDROME; EMBRYO; FGF8 GENE; GENE; GENE FUNCTION; GENE INTERACTION; GENE MUTATION; HYPOTHESIS; MORPHOGENESIS; MOUSE; NEURAL CREST; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TBX1 GENE;

ANIMALS; AORTA, THORACIC; DIGEORGE SYNDROME; GENE EXPRESSION; METALLOENDOPEPTIDASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MORPHOGENESIS; MUTATION; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS; TIME FACTORS;

PAA;

EID: 0042859917     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/dvdy.10358     Document Type: Article

References (25)

1. Abu-Issa R, Smyth G, Smoak I, Yamamura K-I, Meyers EN. 2002. Fgf8 is required for pharyngeal arch development and cardiovascular patterning in the mouse. Development 129:4613-4625.
2. Albrecht U, Elchele G, Helms JA, Lu HC. 1997. Visualization of gene expression patterns by in situ hybridization. In: Daston GP, editor. Molecular and cellular methods in developmental toxicology. New York: CRC Press. Inc. p 23-48.
3. Bockman DE, Redmond ME, Kirby ML. 1989. Alteration of early vascular development after ablation of cranial neural crest. Anat Rec 225:209-217.
4. Clouthier DE, Hosoda K, Richardson JA, Williams SC, Yanagisawa H, Kuwaki T, Kumada M, Hammer RE, Yanagisawa M. 1998. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development 125:813-824.
5. Clouthier DE, Williams SC, Yanagisawa H, Wieduwilt M, Richardson JA, Yanagisawa M. 2000. Signaling pathways crucial for craniofacial development revealed by endothelin-A receptor-deficient mice (in process citation). Dev Biol 217:10-24.
6. Clouthier DE, Williams SC, Hammer RE, Richardson JA, Yanagisawa M. 2003. Cell-autonomous and non-autonomous actions of endothelin-A receptor signaling in craniofacial and cadiovascular development. Dev Biol (in press).
7. Frank DU, Fotheringham LK, Brewer JA, Muglia LJ, Tristani-Firouzi M, Capecchi MR, Moon AM. 2002. An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development 129:4591-4603.
8. Jerome LA, Papaioannou VE. 2001. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 27:286-291.
9. Kochilas L, Merscher-Gomez S, Lu MM, Potluri V, Liao J, Kucherlapati R, Morrow B, Epstein JA. 2002. The role of neural crest during cardiac development in a mouse model of DiGeorge syndrome. Dev Biol 251:157-166.
10. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao WH, Kamada N. 1994. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368:703-710.
11. Kurihara Y, Kurihara H, Maemura K, Kuwaki T, Kumada M, Yazaki Y. 1995. Impaired development of the thyroid and thymus in endothelin-1 knockout mice. J Cardiovasc Pharmacol 26:S13-S16.
12. Kurihara H, Kurihara Y, Nagai R, Yazaki Y. 1999. Endothelin and neural crest development. Cell Mol Biol 45:639-651.
13. Lindsay EA, Baldini A. 2001. Recovery from arterial growth delay reduces penetrance of cardiovascular defects in mice deleted for the DiGeorge syndrome region. Hum Mol Genet 10:997-1002.
14. Lindsay EA, Botta A, Jurecic V, Carattini-Rivera S, Cheah Y-C, Rosenblatt HM, Bradley A, Baldini A. 1999. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401:379-383.
15. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T, Jurecic V, Ogunrinu G, Sutherland HF, Scambler PJ, Bradley A, Baldini A. 2001. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410:97-101.
16. Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Min Lu MM, Xavier RJ, Demay MB, Russell RG, Factor S, Tokooya K, St, Jore B, Lopez M, Pandita RK, Lia M, Carrion D, Xu H, Schorle H, Kobler JB, Scambler PJ, Wynshaw-Boris A, Skoultchi Al, Morrow BE, Kucherlapati R. 2001. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104:619-629.
17. Neufeld G, Cohen T, Shraga N, Lange T, Kessler O, Herzog Y. 2002. The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 12:13-19.
18. Schlaeger TM, Qin Y, Fujiwara Y, Magram J, Sato TN. 1995. Vascular endothelial cell lineage-specific promoter in transgenic mice. Development 121:1089-1098.
19. Schlaeger TM, Bartunkova S, Lawitts JA, Teichmann G, Risau W, Deutsch U, Sato TN. 1997. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci U S A 94:3058-3063.
20. Trumpp A, Depew MJ, Rubenstein JL, Bishop JM, Martin GR. 1999. Cre-mediated gene inactivation demonstrates that FGF8 is required for cell survival and patterning of the first branchial arch. Genes Dev 13:3136-3148.
21. Vitelli F, Morishima M, Taddei I, Lindsay EA, Baldini A. 2002a. Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Hum Mol Genet 11:915-922.
22. Vitelli F, Taddei I, Morishima M, Meyers EN, Lindsay EA, Baldini A. 2002b. A genetic link between Tbx1 and fibroblast growth factor signaling. Development 129:4605-4611.
23. Yanagisawa H, Hammer RE, Richardson JA, Williams SC, Clouthier DE, Yanagisawa M. 1998a. Role of endothelin-1/ endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice. J Clin Invest 102:22-33.
24. Yanagisawa H, Yanagisawa M, Kapur RP, Richardson JA, Williams SC, Clouthier DE, de Wit D, Emoto N, Hammer RE. 1998b. Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 125:825-836.
25. Yanagisawa H, Hammer RE, Richardson JA, Emoto N, Williams SC, Takeda S, Clouthier DE, Yanagisawa M. 2000. Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J Clin Invest 105:1373-1382.